Dec 27 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* SUBMITTED A COMPLETE CLINICAL BRIEFING PACKAGE TO U.S. FDA FOR ITS FIRST PRODUCT TLX591-CDX1
Dec 27 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* SUBMITTED A COMPLETE CLINICAL BRIEFING PACKAGE TO U.S. FDA FOR ITS FIRST PRODUCT TLX591-CDX1